Cite
HARVARD Citation
Elinzano, H. et al. (2021). Nanoliposomal Irinotecan and Metronomic Temozolomide for Patients With Recurrent Glioblastoma. American journal of clinical oncology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Elinzano, H. et al. (2021). Nanoliposomal Irinotecan and Metronomic Temozolomide for Patients With Recurrent Glioblastoma. American journal of clinical oncology. p. . [Online].